key: cord-0720489-ww7epvp7
authors: Kumar, Parul; Lynch, Sean; Shahar, Sivan; Klepacz, Lidia; Ferrando, Stephen J.
title: Olfactory Hallucinations in the Context of COVID-19
date: 2021-05-05
journal: J Acad Consult Liaison Psychiatry
DOI: 10.1016/j.jaclp.2021.04.006
sha: 1743deff05d1a8d265b8f6e14ddda0fc35fabb4c
doc_id: 720489
cord_uid: ww7epvp7

nan

Coronavirus disease 2019 (COVID-19) has wide-ranging physical and neuropsychiatric complications. While anosmia has been recognized as a hallmark of COVID-19, as per the review article by Whittaker et al. 5 of 31 studies reported distorted or "phantom" olfactory perceptions associated with COVID-19. 1 The presentation of COVID-19 through "phantom" or "hallucinatory" phenomena may pose differential diagnostic challenges for patients with schizophrenia-spectrum illness. Patients with schizophrenia-spectrum illness are at an increased risk for COVID-19 related morbidity and mortality due to a host of behavioral, psychosocial and medical factors. 2, 3 We present a case report of a patient with a history of a schizoaffective disorder who presented with new-onset olfactory hallucinations in the context of COVID-19 infection and discuss the differential diagnostic considerations.

A 38-year-old White female with a history of schizoaffective disorder and migraines presented to the emergency department with manic and psychotic symptoms in the context of nonadherence to medications. On evaluation, she presented with manic symptoms characterized by racing thoughts, distractibility, increased energy, decreased While in the emergency department, the patient underwent investigative studies out of concern that the olfactory hallucinations might reflect an acute central nervous system insult, such as a seizure disorder or acute head injury. Neurological examination was normal, and Brain Computed Tomography showed no abnormalities. A SARS-CoV-2 RNA PCR test was obtained due to her previous symptoms of transient anosmia and the alteration in taste. The patient was found to be SARS-CoV-2 positive. She did not experience any other typical constitutional, respiratory or infectious symptoms of COVID-19. Chest X-ray and laboratory studies, including WBC, Ferritin, RPR, and coagulation studies were normal.

The patient was admitted and her medication regimen was adjusted to include Aripiprazole, Haloperidol, Topiramate, and Fluoxetine with resolution of her psychotic symptoms at discharge. The patient reported resolution of the olfactory hallucinations within 2 days of being admitted with no further medical intervention required. She was discharged home with scheduled outpatient psychiatric follow-up.

In a patient with a psychotic disorder, olfactory hallucinations may be associated In terms of COVID-19 illness, parosmia and phantosmia, have been described in approximately 8 and 9.5% of COVID-19-affected individuals respectively. 5 The clinical course of these symptoms in COVID-19 illness is less clear. While patients with COVID-19 "long hauler" syndrome report persistent loss of smell and taste, the frequency, magnitude and duration have yet to be described.

In conclusion, we present a case of new-onset olfactory hallucinations related to SARS-CoV-2 infection in a patient with schizoaffective disorder. While we cannot be certain about the etiology of olfactory hallucinations in this patient, it is our conclusion that these symptoms were the only presenting symptom of her COVID-19 infection. The symptoms were preceded by anosmia, were transient, and had never been experienced by this patient before. It is unclear if patients with schizophrenia are more likely than others to experience olfactory changes with COVID-19, however it is clear that they are at higher risk of contracting COVID-19. Thus, onset of such a symptom in patients with J o u r n a l P r e -p r o o f

Neurological Manifestations of COVID-19: A systematic review and current update

Increased risk of COVID -19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry. 2020; Epub ahead of print

Association of Psychiatric Disorders With Mortality Among Patients With COVID-19

Distortion of Olfactory Perception: Diagnosis and Treatment

More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis